Ensysce Biosciences (ENSC) News Today → The Weight Loss Pill That Could Disrupt a $32 Billion Industry (From Behind the Markets) (Ad) Free ENSC Stock Alerts $0.56 -0.01 (-2.04%) (As of 05:26 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineEnsysce Biosciences (NASDAQ:ENSC) Stock Price Up 2.8%americanbankingnews.com - May 2 at 2:45 AMEnsysce Biosciences, Inc.: Ensysce Biosciences' CEO Dr. Lynn Kirkpatrick Featured in Xtalks Clinical Edge Magazinefinanznachrichten.de - April 25 at 9:03 AMEnsysce Biosciences’ CEO Dr. Lynn Kirkpatrick Featured in Xtalks Clinical Edge Magazinefinance.yahoo.com - April 25 at 9:03 AMEnsysce Biosciences, Inc.: Ensysce Biosciences to Participate in the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conferencefinanznachrichten.de - April 9 at 1:46 PMENSC Stock Earnings: Ensysce Biosciences Misses EPS, Beats Revenue for Q4 2023investorplace.com - March 18 at 12:01 PMENSC Striding Toward Opioid Replacementfinance.yahoo.com - March 15 at 2:35 PMEnsysce Biosciences, Inc.: Ensysce Biosciences Reports Fourth Quarter and Full Year 2023 Financial Resultsfinanznachrichten.de - March 15 at 9:35 AMEnsysce Biosciences Stock (NASDAQ:ENSC), Short Interest Reportbenzinga.com - February 21 at 3:25 PMEnsysce Biosciences Announces Successful Meeting with FDA for PF614-MPAR, a Next Generation Opioid with Overdose Protectionfinance.yahoo.com - February 21 at 10:25 AMENSC: Investors Should Pay Attentionfinance.yahoo.com - February 16 at 1:35 PMEnsysce Biosciences, Inc.: Ensysce Biosciences Announces Publication of Clinical Bioequivalence Manuscriptfinanznachrichten.de - February 15 at 12:33 PMEnsysce Biosciences Announces Publication of Clinical Bioequivalence Manuscriptfinance.yahoo.com - February 15 at 12:33 PMEnsysce Biosciences falls on exercise of warrants for $4.7M gross proceedsmsn.com - February 13 at 7:42 PMEnsysce Biosciences, Inc. Announces Exercise of Warrants for $4.7 Million Gross Proceedsfinance.yahoo.com - February 13 at 9:41 AMEnsysce Biosciences, Inc.: Ensysce Biosciences Selected to Present at American Association of Pain Medicine Annual Conferencefinanznachrichten.de - February 6 at 9:49 AMEnsysce Biosciences Selected to Present at American Association of Pain Medicine Annual Conferencefinance.yahoo.com - February 6 at 9:49 AMEnsysce Biosciences Announces Positive End of Phase 2 Meeting with FDA for PF614 to Treat Severe Painfinance.yahoo.com - January 31 at 9:28 AMEnsysce Biosciences, Inc.: Ensysce Biosciences to Present Groundbreaking Oral Overdose Protection for Opioids at the 5th Annual NIH HEAL Meetingfinanznachrichten.de - January 25 at 10:34 AMEnsysce Biosciences to Present Groundbreaking Oral Overdose Protection for Opioids at the 5th Annual NIH HEAL Meetingfinance.yahoo.com - January 25 at 10:34 AMEnsysce rallies 22% on FDA update for overdose-resistant opioidseekingalpha.com - January 23 at 6:29 PMOpioid Developer Ensysce Biosciences Stock Is Shooting Higher Today - Here's Whyfinance.yahoo.com - January 23 at 6:29 PMENSC Announces Major FDA Designationfinance.yahoo.com - January 23 at 1:29 PMEnsysce Biosciences, Inc.: Ensysce Biosciences Announces FDA Breakthrough Therapy Designation Granted for PF614-MPARfinanznachrichten.de - January 23 at 8:28 AMEnsysce Biosciences Announces FDA Breakthrough Therapy Designation Granted for PF614-MPARfinance.yahoo.com - January 23 at 8:28 AMEnsysce Biosciences files to sell common stock, warrantsmsn.com - January 17 at 9:12 AMEnsysce Biosciences, Inc.: Ensysce Biosciences Issues 2024 Shareholder Letterfinanznachrichten.de - January 8 at 11:31 AMEnsysce Biosciences Issues 2024 Shareholder Letterfinance.yahoo.com - January 8 at 11:31 AMEnsysce Biosciences Postpones Special Meeting of Stockholders to December 29, 2023finance.yahoo.com - December 19 at 8:03 PMEnsysce Biosciences Announces Key Efficacy Data for Lead Analgesicfinance.yahoo.com - December 14 at 9:18 AMEnsysce Biosciences Discusses TAAP and MPAR(R) Applications and OncoZenge Partnership with The Stock Day Podcastfinance.yahoo.com - December 11 at 10:24 AMEnsysce Biosciences Inc Ordinary Sharesmorningstar.com - December 7 at 3:47 PMmarketbeat.com - November 30 at 2:40 PMEnsysce Biosciences, Inc.: Ensysce Biosciences and OncoZenge Announce Letter of Intent for the Co-development of BupiZenge in the United Statesfinanznachrichten.de - November 29 at 9:44 AMEnsysce Biosciences Announces Completion of $1.7 Million Convertible Note Financingfinance.yahoo.com - November 29 at 9:44 AMEnsysce Biosciences and OncoZenge Announce Letter of Intent for the Co-development of BupiZenge(TM) in the United Statesfinance.yahoo.com - November 28 at 9:09 AMEnsysce Biosciences and OncoZenge Announce Letter of Intent for the Co-development of BupiZenge(TM) in the United Statesfinance.yahoo.com - November 28 at 9:09 AMEnsysce Biosciences Announces Enrollment Completion for PF614-201 Clinical Studyfinance.yahoo.com - November 16 at 8:34 AMENSC Releases Earnings and Highlights Progressfinance.yahoo.com - November 10 at 12:48 PMEnsysce Biosciences Reports Third Quarter 2023 Financial Resultsfinance.yahoo.com - November 9 at 9:03 PMEnsysce Biosciences Secures $1.7 Million Convertible Note Financingfinance.yahoo.com - October 24 at 10:36 AMEnsysce Biosciences Announces Poster Presentation at the AAPS 2023 PharmSci 360finance.yahoo.com - October 18 at 8:38 AMEnsysce Biosciences Releases "Highlights Video" of PAINWeek 2023 Symposiumfinance.yahoo.com - October 13 at 10:06 AMEnsysce Biosciences, Inc.: Ensysce Biosciences to Chair the Fierce New Product Planning Summit 2023finanznachrichten.de - October 3 at 9:04 AMEnsysce Biosciences to Chair the Fierce New Product Planning Summit 2023finance.yahoo.com - October 3 at 9:04 AMEnsysce Biosciences Announces Completion of Site Initiation Visit for PF614-201 Clinical Studyfinance.yahoo.com - September 26 at 10:22 AMEnsysce Biosciences (ENSC) Receives a Buy from H.C. Wainwrightmarkets.businessinsider.com - September 25 at 10:58 AMEnsysce Biosciences to Host Research and Development FAQ Session Following PAINWeek Symposium on September 21, 2023finance.yahoo.com - September 19 at 1:18 PMEnsysce Biosciences, Inc.: Ensysce Biosciences Completes Scale Up Manufacture of PF614 to Support Phase 3 Studiesfinanznachrichten.de - September 14 at 9:05 AMEnsysce Biosciences Completes Scale Up Manufacture of PF614 to Support Phase 3 Studiesfinance.yahoo.com - September 14 at 9:05 AMEnsysce Biosciences, Inc.: Ensysce Presents "A New Generation of Safer Pain Treatments"finanznachrichten.de - September 7 at 8:43 AM Get Ensysce Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ENSC and its competitors with MarketBeat's FREE daily newsletter. Email Address AI “wealth window” is closing June 25th (Ad)Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry. I put together this personal video [HERE]… ENSC Media Mentions By Week ENSC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ENSC News Sentiment▼0.000.37▲Average Medical News Sentiment ENSC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ENSC Articles This Week▼11▲ENSC Articles Average Week Get Ensysce Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ENSC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: GNPX News LGVN News THAR News DRUG News ARTL News XCUR News PTPI News GTBP News CPHI News LIPO News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ENSC) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyAI “wealth window” is closing June 25thParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityThe AI Stock that’s Disrupting Every IndustryStockEarningsWatch this FREE trading tutorial while it’s still availableInvestorPlace[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ensysce Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
